Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation
13 sept. 2024 06h45 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent” or the “Company”) today announced that it has entered into an agreement to resolve the...
SHAREHOLDER ALERT: Morris Kandinov Investigating EBS, JRVR, EGIO, and HAFC; Shareholders are Encouraged to Contact the Firm
20 sept. 2023 15h09 HE
|
Morris Kandinov, LLP
SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Emergent BioSolutions Inc., James River Group...
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT
11 mai 2023 06h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., May 11, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2023 Annual Meeting of Stockholders will be held in a virtual-only format via live...
Emergent BioSolutions Announces Stock Repurchase Program
11 nov. 2021 16h05 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized management to repurchase up to $250 million of...
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Live Ventures, CorMedix, Emergent BioSolutions, and Generac on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
02 nov. 2021 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Live Ventures...
NYSE: EBS Investor Notice: Lawsuit against Emergent BioSolutions Inc announced by the Shareholders Foundation
31 août 2021 08h00 HE
|
Shareholders Foundation, Inc.
SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Emergent BioSolutions Inc (NYSE: EBS) shares. Investors,...
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period - by PMI
22 juil. 2021 10h35 HE
|
PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) -- The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$ 69.0 billion by 2030 and is anticipated to...
EBS UPDATED DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Informs Emergent BioSolutions Inc. Investors of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday – EBS
18 juin 2021 10h11 HE
|
The Rosen Law Firm PA
NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Churchill, Emergent BioSolutions, and Verus International and Encourages Investors to Contact the Firm
02 juin 2021 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for FUV, EBS, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
02 juin 2021 11h00 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...